-
第 31 楼 / Sunmax
- 时间: 2010-9-21 09:02
-
-
- 时间: 2010-9-27 12:46
-
-
- 时间: 2010-10-04 17:00
-
- 时间: 2010-10-04 20:42
-
- 时间: 2010-10-05 09:40
-
- 时间: 2010-10-11 12:04今天又涨。看来这个股票可以做长期。
写道:BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Cancer Treatment Centers of America (CTCA), located in Tulsa, Oklahoma, has purchased a BSD-2000 Hyperthermia System (BSD-2000). CTCA in Tulsa is a state-of-the-art hospital that is totally focused on treating cancer patients and provides the most advanced therapeutic resources in cancer treatment (http://www.cancercenter.com/southwestern-hospital.cfm). CTCA is a network of hospitals and one of the premier providers of cancer care in the world. The CTCA hospitals were recently recognized by the Commission on Cancer of the American College of Surgeons as "offering the very best in cancer care." This advanced cancer treatment facility was designed in cooperation with cancer patients and their care givers. -
- 时间: 2010-10-27 08:58
-
- 时间: 2010-10-27 09:28
-
- 时间: 2010-10-27 09:50
-
- 时间: 2010-10-27 11:03看到这个报道，
www.investmentu.com/20...igher.html
写道:Since 1978, BSD Medical Corporation (Nasdaq: BSDM) has developed some of the world’s most revolutionary cancer treatments. In 2005, the company won the Frost & Sullivan “Technology Innovation of the Year Award” for its BSD-2000 system.
But its biggest moneymaker to date is the MicroThermX.
BSD’s patented “phased-array” technology, the lifeblood of the MTX, generates heat that allows doctors to kill massive clusters of cancer cells. A recent study by the University of Oklahoma confirms this.
According to the report, phased-array treatment was effective at multiple stages. When treating early-stage breast cancer, it reduced the tumor size in 80% of subjects. When used to treat large breast cancer tumors, tumor size decreased by 88.4% compared with 58.8% for those receiving chemotherapy.
And other reports, such as those published in The Journal of Radiology and Cancer Therapy, have confirmed that this technology offers numerous advantages over today’s therapies. That includes deeper penetration of cancerous tissues and faster recovery times. It even outperforms RF treatment, the current leader.
如果没有其他的公司推出类似的产品，BSD的会一直在领先的地位，毕竟88.4% 和 58.8% 相差还是很大的。
BSDM
